Update from BioMarin Phase 3 Trial

BioMarin’s investigational gene therapy for hemophilia A has not been approved for use; clinical trials are ongoing.

Please click this link to read an update from BioMarin on a phase 3 trial.

Source: National Hemophilia Foundation